4409-34-1 ((17α)-17-Hydroxyestr-4-en-3-one,(17α)-17-hydroxyestr-4-en-3-one)

(17α)-17-Hydroxyestr-4-en-3-one;17alpha-Hydroxyestr-4-en-3-one;Estr-4-en-3-one, 17alpha-hydroxy-;estr-4-en-3-one, 17-hydroxy-, (17alpha)-;17α-Nandrolone (Epi-nandrolone);17-epi-Nandrolone;17-epi-Nandrolone (1.0mg/ml in Acetonitrile);NS00123831;17alpha-nandrolone;(8R,9S,10R,13S,14S,17R)-17-hydroxy-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one;CHEBI:183973;Norepitestosterone;4409-34-1;Epinandrolone;17alpha-Hydroxyestr-4-en-3-one; (17alpha)-19-Nortestosterone; 17alpha-Nandrolone; 19-Nor-17alpha-testosterone; Epinandrolone; Norepitestosterone;20708-81-0;DTXSID901016522;19-Nor-17alpha-testosterone;

NPAGDVCDWIYMMC-SHRADXDESA-N

1S/C18H26O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h10,13-17,20H,2-9H2,1H3/t13-,14+,15+,16-,17+,18-/m0/s1

O[C@@H]1CC[C@H]2[C@@H]3CCC4=CC(CC[C@@H]4[C@H]3CC[C@@]21C)=O